Literature DB >> 12456565

How do we treat wheezing infants? Evidence or anecdote.

R J Chavasse1, Y Bastian-Lee, P Seddon.   

Abstract

Consultant paediatricians were questioned about their management of wheezing disorders in infants. Salbutamol was the preferred bronchodilator for recurrent wheeze, whereas ipratropium was preferred in viral bronchiolitis. Doses of both medications varied widely. Both inhaled and oral corticosteroids were considered by most respondents. Practice does not clearly follow guidelines or evidence and presumably continues to be based on anecdote.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12456565      PMCID: PMC1755817          DOI: 10.1136/adc.87.6.546

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  5 in total

1.  Randomized trial of salbutamol via metered-dose inhaler with spacer versus nebulizer for acute wheezing in children less than 2 years of age.

Authors:  L Rubilar; J A Castro-Rodriguez; G Girardi
Journal:  Pediatr Pulmonol       Date:  2000-04

2.  Persistent wheezing in infants with an atopic tendency responds to inhaled fluticasone.

Authors:  R J Chavasse; Y Bastian-Lee; H Richter; T Hilliard; P Seddon
Journal:  Arch Dis Child       Date:  2001-08       Impact factor: 3.791

3.  Treatment of recurrent acute wheezing episodes in infancy with oral salbutamol and prednisolone.

Authors:  G F Fox; M J Marsh; A D Milner
Journal:  Eur J Pediatr       Date:  1996-06       Impact factor: 3.183

4.  Treatment of respiratory syncytial virus bronchiolitis: 1995 poll of members of the European Society for Paediatric Infectious Diseases.

Authors:  J L Kimpen; U B Schaad
Journal:  Pediatr Infect Dis J       Date:  1997-05       Impact factor: 2.129

5.  Nebulised therapy in acute severe bronchiolitis in infancy.

Authors:  G M Stokes; A D Milner; I G Hodges; R L Henry; M C Elphick
Journal:  Arch Dis Child       Date:  1983-04       Impact factor: 3.791

  5 in total
  1 in total

1.  Impact of a bronchiolitis clinical care pathway on treatment and hospital stay.

Authors:  Claire Walker; Susan Danby; Steve Turner
Journal:  Eur J Pediatr       Date:  2011-12-23       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.